IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

DSM's net profit falls 13% in the first quarter as performance materials sales decline

2:15 AM MDT | May 2, 2013 | Francinia Protti-Alvarez

DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the company announced today. Ebitda, meanwhile, rose by 1.6% from €306 million during the first quarter of 2012, to €311 million in the latest reporting period. Net sales also increased by about 4%, to €2.38 billion during the first quarter of 2013, from €2.29 billion in the same period the year before. Life sciences delivered the company's growth once again, driven...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa